Eli Lilly pulls ahead of Novo in obesity drug gold rush as new players crowd in

The global weight-loss drug market, once dominated by Novo Nordisk, is undergoing a dramatic transformation. On Friday, the Danish pharmaceutical giant announced it would replace its long-serving chief executive, Lars…